双相情感障碍药物治疗的临床实践  

Practical considerations in the pharmacological treatment of bipolar disorder

作　　者：刘铁榜[1] Liu Tiebang(Shenzhen Kangning Hospital,Shenzhen Mental Health Center,Shenzhen China)

机构地区：[1]深圳市康宁医院,深圳市精神卫生中心,广东深圳518020

出　　处：《四川精神卫生》2023年第6期481-484,共4页Sichuan Mental Health

摘　　要：双相情感障碍是临床常见的情感障碍之一,起病年龄较早、患病率较高,但误诊率和漏诊率较高,患者预后往往较差。目前,双相情感障碍的药物治疗选择仍存在较大差异。本文就双相情感障碍治疗药物的适应证、疗效以及不良反应进行探讨,以期为双相情感障碍患者的治疗提供参考。Bipolar disorder is one of the most common mood disorders characterized by an early age of onset and high prevalence rate,and patients tent to have poor prognosis due to high misdiagnosis rate and incomplete diagnosis rate.At present,existing pharmacological treatment for bipolar disorder remains highly variable.Therefore,this paper presents a review of indications of the medications,clinical therapeutic effect and adverse drug reactions,thus providing references for the pharmaceutical treatment of bipolar disorder.

关 键 词：双相情感障碍 锂盐 抗抽搐药 抗抑郁剂 

分 类 号：R749[医药卫生—神经病学与精神病学]